Abstract: A resource transfer method includes obtaining, by using a target application, a resource transfer request triggered by a target user, where the resource transfer request includes verification information used to perform resource transfer processing and identity feature information of the target user. By using the target application, verifying the verification information, and invoking, if the verification succeeds by using the target application, a local device management rule, and determining, by using the local device management rule, whether the identity feature information of the target user matches identity feature information of a pre-registered user. If the identity feature information of the target user matches the identity feature information of the pre-registered user, sending the resource transfer request to a first server corresponding to the target application to trigger, based on the resource transfer request, the first server to perform resource transfer processing.

Abstract: The present disclosure provides a cultivation method of morels and belongs to the technical field of cultivation of edible fungi. After nutrient contents that can be metabolized and utilized by morel mycelia are scientifically matched, sterilization treatment of exogenous nutrients is eliminated, and the exogenous nutrients are directly compressed for forming. Formed exogenous nutrient blocks and spawn is sowed and covered with soil, so as to realize a potential difference between “rich” and “poor” nutrients in a physical space. When the spawn germinate to form a mycelium network, the mycelia will enter a nutrient-rich exogenous nutrient area, secrete various extracellular enzymes to decompose and utilize these exogenous nutrient blocks, and transport them to a nutrient-poor mycelium network for storage, so as to complete nutrient assimilation and absorption, and reserve energy for later sexual reproduction.

Abstract: A display screen and an electronic device are provided. The display screen includes a metal anode layer, a semi-transparent cathode layer, and a pixel unit layer. The metal anode layer includes multiple metal anodes arranged at intervals. The semi-transparent cathode layer includes multiple semi-transparent cathodes. The pixel unit layer is sandwiched between the metal anode layer and the semi-transparent cathode layer. The pixel unit layer includes multiple pixel units arranged at intervals. Each pixel unit is located between a corresponding metal anode and a corresponding semi-transparent cathode. The display screen has a preset region, and in the preset region of the display screen, the semi-transparent cathode layer further includes a light-shielding portion and light-transmitting regions surrounded by the light-shielding portion. The light-shielding portion is connected with the multiple semi-transparent cathodes.

Abstract: A recombinant Flagrp170 protein and pharmaceutical compositions comprising a Flagrp170 protein and related molecules encoding same, and cells presenting such a protein are provided. The Flagrp170 protein comprises an NF-?B-activating domain of Flagellin and an ATP-binding domain truncated Grp170. The pharmaceutical compositions of the invention can be used for the treatment or prevention of cancer or infectious disease.

Abstract: A recombinant Flagrp170 protein and pharmaceutical compositions comprising a Flagrp170 protein and related molecules encoding same, and cells presenting such a protein are provided. The Flagrp170 protein comprises an NF-?B-activating domain of Flagellin and an ATP-binding domain truncated Grp170. The pharmaceutical compositions of the invention can be used for the treatment or prevention of cancer or infectious disease.

Abstract: A recombinant Flagrp170 protein and pharmaceutical compositions comprising a Flagrp170 protein and related molecules encoding same, and cells presenting such a protein are provided. The Flagrp170 protein comprises an NF-KB-activating domain of Flagellin and an ATP-binding domain truncated Grp170. The pharmaceutical compositions of the invention can be used for the treatment or prevention of cancer or infectious disease.

Abstract: A recombinant Flagrp170 protein and pharmaceutical compositions comprising a Flagrp170 protein and related molecules encoding same, and cells presenting such a protein are provided. The Flagrp170 protein comprises an NF-KB-activating domain of Flagellin and an ATP-binding domain truncated Grp170. The pharmaceutical compositions of the invention can be used for the treatment or prevention of cancer or infectious disease.